Stocks, oil slide as Omicron worries push investors to safe havens



(Updates through close of U.S. trading)

By David Randall

NEW YORK, Nov 30 (Reuters) - Global stock benchmarks and oil prices fell sharply on Tuesday after drugmaker Moderna warned that existing vaccines are unlikely to be as effective against the new coronavirus variant, spurring investors to pile into safe-haven assets such as government bonds and the yen.

"There is no world, I think, where (the effectiveness) is the same level," Moderna's MRNA.O chief executive, Stephane Bancel, told the Financial Times in an interview, comparing the effectiveness against the new Omicron variant to prior variants.

"I think it's going to be a material drop. I just don't know how much because we need to wait for the data. But all the scientists I've talked to ... are like 'this is not going to be good,'" Bancel said.

Bancel said earlier on CNBC that there should be more clarity on the efficacy of COVID-19 vaccines against the Omicron variant in about two weeks, but it could take months to begin shipping a reworked vaccine designed for it.

"It's not good news, and it's coming from someone who should know," said Commonwealth Bank of Australia currency strategist Joe Capurso. "Markets have reacted in exactly the way you'd expect them to."

Losses accelerated after Federal Reserve Chairman Jerome Powell told Congress that high inflation will persist until the middle of next year, leaving the central bank "likely" to discuss speeding up the tapering of the asset-buying program it introduced last year to support the economy during the pandemic.

"We've long maintained that the Fed is the ultimate owner of the 'transitory' characterization and the chair's decision to move beyond that is a decidedly hawkish step," said Ian Lyngen, head of U.S. rates strategy at BMO Capital Markets.

MSCI's gauge of stocks across the globe .MIWD00000PUS shed 1.39% following broad declines in Europe and Asia. Concerns that the new variant would lead to more travel restrictions continued to hammer European travel and leisure stocks, which posted their biggest monthly fall since the initial COVID-19 lockdowns in March 2020.

In the United States, the Dow Jones Industrial Average .DJI fell 652.22 points, or 1.86%, to 34,483.72, the S&P 500 .SPX lost 88.26 points, or 1.90%, to 4,567.01, and the Nasdaq Composite .IXIC dropped 245.14 points, or 1.55%, to 15,537.69.

Benchmark 10-year notes US10YT=RR last rose 26/32 in price to yield 1.4426%, from 1.529% late on Monday.

Omicron worries sent the yield on 10-year German Bunds - regarded as one of the safest assets in the world - to its lowest level in just over a week at -0.345% DE10YT=RR .

The Japanese yen JPY=EBS - traditionally viewed as a safe harbor due to its role as a funding currency - was near its highest level of the month.

U.S. crude CLc1 fell 4.52% to $66.79 per barrel and Brent LCOc1 was at $70.57, down 3.91% on the day



Powell puts faster bond-buying taper on Fed's Christmas table

Oil falls on vaccine efficacy worries; WTI down over 6%

US STOCKS-Wall St drops over 1% on Powell's faster taper
comments, Omicron worries



Reporting by David Randall; Editing by Lisa Shumaker and Leslie Adler

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.